New depression pill goes Head-to-Head with standard treatment
Disease control
Completed
This study tested if a new, once-daily extended-release capsule of the antidepressant levomilnacipran is effective and safe for treating major depressive disorder. It directly compared it against an already approved antidepressant, duloxetine, in 392 adults with moderate to sever…
Phase: PHASE3 • Sponsor: Zhejiang Huahai Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC